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Prevalence and Antimicrobial Resistance of Bacteria in 
Children With Acute Otitis Media and Ear Discharge
A Systematic Review
Saskia Hullegie, MD, MSc,* Roderick P. Venekamp, MD, PhD,* Thijs M. A. van Dongen, MD, PhD,*  
Alastair D. Hay, MD, MRCP, MRCGP,† Michael V. Moore, MD, MRCP, FRCGP,‡  
Paul Little, MD, MRCP, FRCGP,‡ Anne G. M. Schilder, MD, PhD,*§ and Roger A. M. J. Damoiseaux, MD, PhD* 
Background: Of children with acute otitis media (AOM), 15%–20% pre-
sent with acute onset ear discharge due to a spontaneous perforation of the 
tympanic membrane (AOMd). This review aims to quantify the prevalence 
and antimicrobial resistance (AMR) status of bacteria in children with 
AOMd in the pneumococcal conjugate vaccine (PCV) era.
Methods: Systematic searches were performed in PubMed, EMBASE and 
Cochrane Library from inception to June 7, 2019. Two reviewers extracted 
relevant data and assessed risk of bias independently. All English studies 
reporting any prevalence and/or AMR data of bacterial middle ear isolates 
from children with AOMd were included. Risk of bias was assessed using 
the Joanna Briggs Institute Critical Appraisal checklist.
Results: Of 4088 unique records retrieved, 19 studies (10,560 children) 
were included. Overall quality was judged good. Streptococcus pneumo-
niae (median 26.1%, range 9.1%–47.9%), Haemophilus influenzae (median 
18.8%, range 3.9%–55.3%), Staphylococcus aureus (median 12.3%, 
range 2.3%–34.9%) and Streptococcus pyogenes (median 11.8%, range 
1.0%–30.9%) were the most prevalent bacteria. In 76.0% (median, range 
48.7%–100.0%, 19 studies, 1,429 children) any bacterium was identified. 
AMR data were sparse and mainly limited to S. pneumoniae. We found no 
evidence of a clear shift in the prevalence of bacteria and AMR over time.
Conclusions: In children with AOMd, S. pneumoniae and H. influenzae are the 
2 predominant bacteria, followed by S. aureus and S. pyogenes in the post-PCV 
era. AMR data are sparse and no clearly change over time was observed. Ongo-
ing surveillance of the microbiology profile in children with AOMd is warranted 
to guide antibiotic selection and to assess the impact of children’s PCV status.
Key Words: acute otitis media, ear discharge, otopathogens, antimicrobial 
resistance, review
(Pediatr Infect Dis J 2021;40:756–762)
Acute otitis media (AOM) is one of the most common child-hood infections and a leading cause of doctor consultations 
and antibiotic prescribing worldwide.1,2 Around 15%–20% of 
children with AOM present with acute onset ear discharge due to 
a spontaneous perforation of the tympanic membrane (AOMd).3,4 
In contrast to widespread beliefs, children with AOMd have simi-
lar levels of ear pain and feel less well at presentation than those 
without ear discharge (AOMwd). Also, children with AOMd 
have a higher disease burden with higher rates of ear pain and/
or fever at 3–7 days and more AOM recurrences and hearing 
problems at 3 months compared with children without ear dis-
charge.3,4 Antibiotics are more effective in children with AOMd 
than in those with AOMwd; number needed to treat to achieve 
resolution of ear pain and/or fever at days 3 to 7: 3 versus 8, 
respectively.3 AOM guidelines therefore recommend clinicians 
to consider immediate antibiotic prescribing in children with 
AOMd,5,6 in contrast to AOMwd, for which a watchful waiting 
approach is recommended for otherwise healthy children with 
nonsevere unilateral disease.5,6
It has been suggested that the differences in clinical pic-
ture and disease course between AOMwd and AOMd might be 
attributed to differences in causative pathogens. A 2016 system-
atic review including 38 published reports of microbiology of 
children with AOMwd found that Streptococcus pneumoniae 
(average detection rate of 27.8%), Haemophilus influenzae 
(23.1%) and Moraxella catarrhalis (7.0%) are the most com-
mon bacteria associated with AOMwd globally.7 Streptococ-
cus pyogenes is thought to be more prevalent in children with 
AOMd,8–10 but data are conflicting.9–11 The routine administra-
tion of pneumococcal conjugate vaccines (PCVs) during infancy 
has led to a change in childhood AOM epidemiology.12–14 This 
review aims to provide an overview of the prevalence and anti-
microbial resistance (AMR) of bacteria in children with AOMd 
in the post-PCV era.
MATERIAL AND METHODS
Our review protocol was published on PROSPERO 
(CRD42018100523).15 The review was reported according to the 
most recent PRISMA statement.16
Primary Objective
To provide an up-to-date overview of the prevalence of bacte-
ria and their AMR profile in children with AOMd in the post-PCV era.
Secondary Objectives
To explore, in children with AOMd, (1) whether the preva-
lence and AMR rates of bacteria varied over time; (2) PCV sta-
tus of participating children impacted our results; and (3) how the 




Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. This 
is an open-access article distributed under the terms of the Creative Commons 
Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), 
where it is permissible to download and share the work provided it is properly 
cited. The work cannot be changed in any way or used commercially without 
permission from the journal.
Review Article
Accepted for publication February 15, 2021
From the *Julius Center for Health Sciences and Primary Care, University Medical Cen-
ter Utrecht, Utrecht University, Utrecht, The Netherlands; †Centre for Academic 
Primary Care, Bristol Medical School: Population Health Sciences, University of 
Bristol, Bristol; ‡Primary Care and Population Sciences Unit, Aldermoor Health 
Centre, University of Southampton, Southampton; and §NIHR UCLH BRC, evi-
dENT, Ear Institute, University College London, London, United Kingdom.
This work is supported by a research grant from the Netherlands Organisation 
for Health Research and Development (ZonMw) [Rational Pharmacotherapy 
5th Open Call grant number 84801 5006]. The funder has no role in design, 
conduct and report of this study.
The authors have no conflicts of interest to disclose.
Address for correspondence: Saskia Hullegie, MD, MSc, HP STR. 6.103, P.O. Box 
85500, 3508 GA Utrecht, The Netherlands. E-mail: s.hullegie@umcutrecht.nl.
Supplemental digital content is available for this article. Direct URL citations 
appear in the printed text and are provided in the HTML and PDF versions of 
this article on the journal’s website (www.pidj.com)
The Pediatric Infectious Disease Journal • Volume 40, Number 8, August 2021 
© 2021 The Author(s). Published by Wolters Kluwer Health, Inc. www.pidj.com | 757
Bacteria and Acute Ear Discharge
Data Sources and Search Strategy
Systematic searches of PubMed, EMBASE and the 
Cochrane Library were performed from inception to June 7, 2019. 
A broad search strategy was designed using a combination of any 
key word relevant to “acute otitis media” and “antibiotic resistance 
or resistant bacteria or individual pathogens” as well as “acute otitis 
media” and “antibiotics,” with database-specific syntaxes (Table, 
Supplemental Digital Content 1, http://links.lww.com/INF/E354).
Patient and Public Involvement
Patients were not involved in the development or conduct 
of this review.
Study Selection
Two reviewers (S.H. and R.P.V.) independently screened 
titles and abstracts of unique records for eligibility using pre-
specified criteria. The same reviewers independently reviewed the 
full texts of potentially eligible papers. Any disagreements were 
resolved by discussion.
All studies reporting any prevalence or AMR data of bac-
terial middle ear isolates from children (0–16 years) with AOMd 
were included. Non-English studies, animal studies, studies con-
ducted before the year 2000 (ie, before routine implementation of 
PCV in infancy), studies focusing on complicated AOM (>25% of 
sample consisting of otitis prone children, children with recurrent 
AOM, treatment failure or hospitalized children) and those from 
which the full text could not be retrieved were excluded. To extent 
the yield of relevant studies, the reference lists of included studies 
were reviewed to identify any additional articles.
Data Extraction and Quality Appraisal
Two review authors (S.H. and R.P.V.) independently extracted 
the following data from the included studies using a standardized 
data extraction form: year of conduction, study design, study pop-
ulation (country, age and the number of participants), prevalence 
and AMR data for the following bacterial isolates: S. pneumoniae, 
nontypeable H. influenzae, M. catarrhalis, S. pyogenes, Staphylo-
coccus aureus and Pseudomonas aeruginosa, methods of sampling 
and antibiotic sensitivity testing and participants’ PCV status.
AMR was primarily defined as nonsusceptibility to antibiot-
ics (resistant and intermediate resistant strains combined).
Quality of included studies was assessed by 2 reviewers 
(S.H. and R.P.V.) independently using the Joanna Briggs Institute 
Critical Appraisal checklist.17 Any disagreements were resolved by 
discussion.
Data Synthesis and Analysis
All statistical analysis were conducted with Rothman’s 
Episheet.18 In descriptive analysis, the prevalence (median and 
range) of bacterial middle ear isolates and their AMR rates to most 
commonly prescribed antibiotics for AOM (penicillin, amoxicillin, 
amoxicillin-clavulanic acid, trimethoprim/sulfamethoxazole, eryth-
romycin, cephalosporin, quinolones and ampicillin). Forrest plots 
were used to summarize these findings. The total prevalence rates 
of individual bacteria were calculated by combining cultures where 
the bacterium was identified as a single isolate and those where 
the bacterium was identified together with other bacteria (mixed 
infection).
We assessed clinical and statistical heterogeneity across 
studies. When studies were sufficiently homogeneous, we aimed to 
calculate pooled prevalences as summary statistic.
In a sensitivity analysis, we excluded studies with <50 par-
ticipants to assess the robustness of research findings. In a further 
sensitivity analysis, we restricted our AMR definition by analyzing 




The literature search yielded 7335 records. Removing dupli-
cates left 4088 unique records. After title and abstract screening, 
302 potentially relevant articles remained (Fig. 1). Of these, 285 
were excluded for various reasons (Fig. 1), leaving 17 studies suit-
able for inclusion. A further 2 studies were retrieved from review-
ing reference lists; these were not identified in our initial search 
strategy because the term “acute” was not mentioned in the titles 
and abstracts. This left 19 studies,4,10,11,19–34 including 10,560 chil-
dren (range 16–5580) suitable for inclusion in this review (Fig. 1).
Study Characteristics
Main study characteristics are presented in Table 1: 9 were 
conducted in Europe,4,10,25,27–30,32,34 7 in Asia,19–21,23,24,26,33 2 in South 
America22,31 and 1 in North America.11 The studies were con-
ducted from 2000 to 2017 with 5 studies conducted after 2011. 
All studies were observational and most (74%) had a prospective 
cohort design. Three studies reported both culture and polymerase 
chain reaction (PCR) results,19,32,34 while the remaining 16 stud-
ies reported culture results only. Seventeen studies used standard 
microbiologic techniques for isolation and identification, including 
the use of chocolate and blood agar, whereas methods were unclear 
in 2 studies.4,31 The prevalence and AMR rates of bacteria could be 
extracted from 18 (95%) and 12 (63%) studies, respectively. Most 
studies (10/19) included only children who did not receive previous 
antibiotic treatment. In 7 studies, no information about antibiotic 
use was reported. In 1 study, 23% of the children received antibiot-
ics in the previous month,34 and in the remaining study, 12.4% of 
the children received antibiotics at the moment of swabbing.28
Eleven studies provided information about the PCV status of 
participants: 1 study reported prevaccination and postvaccination 
data10 and in 2 studies children were not vaccinated,23,27 whereas 
the PCV level of participants varied between 4.4% and 95% in 8 
studies.11,19,25,28–31,34
Quality Appraisal
Overall quality of included studies was judged good (Figure, 
Supplemental Digital Content 2, http://links.lww.com/INF/E355). 
However, data analysis was judged inadequate in 14 studies; in 
most of these studies, antimicrobial susceptibility was not reported 
for all isolates. Data reporting was unclear in 1 study.26
Prevalence of Bacteria
S. pneumoniae (median 26.1%, range 9.1%–47.9%; 18 
studies, 2191 children), H. influenzae (median 18.8%, range 3.9%–
55.3%; 17 studies, 2185 children) and S. aureus (median 12.3%, 
range 5.3%–34.9%; 13 studies, 592 children) were the 3 most 
prevalent bacteria, followed by S. pyogenes (median 11.8%, range 
1.0%–30.9%; 16 studies, 1053 children) (Table 2). The prevalence 
of positive cultures (any bacterium identified) was 76% (median, 
range 48.7%–100%, 17 studies, 3643 children). Pooled prevalences 
were not calculated due to substantial heterogeneity across studies.
The prevalence of bacteria did not clearly change over time 
(Figure, Supplemental Digital Content 3, http://links.lww.com/
INF/E356). Excluding the 3 studies with <50 participants revealed 
similar results as our main analysis. There was no clear evidence of 
a shift in pathogens when stratifying results according to PCV sta-
tus (Figure, Supplemental Digital Content 4, http://links.lww.com/
INF/E357).
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Antimicrobial Resistance
AMR data were mainly reported for S. pneumoniae with 
very limited data reported for the remaining bacteria (Table, Sup-
plemental Digital Content 5, http://links.lww.com/INF/E358). 
Nonsusceptibility rates of S. pneumoniae to commonly used anti-
biotics varied widely between countries. Nonsusceptibility rates 
of pneumococcus to penicillin ranged from 0% to 65.8% (median 
10.0%; 8 studies). Albeit being highly sensitive to quinolones 
(median nonsusceptibility rate 0.9%, range 0%–5.5%; median; 3 
studies), nonsusceptibility rates to other antibiotics varied widely; 
amoxicillin: median 16.7% (range 0%–64.8%; 4 studies), tri-
methoprim/sulfamethoxazole: median 27.3% (range 0%–93.5%; 
5 studies), erythromycin: median 36.5% (range 10.5%–99.1%; 6 
studies) and cephalosporins: median 5.4% (range 0%–63.0%; 6 
studies).
Nonsusceptibility rates of S. pneumoniae did not clearly 
change over time (Fig. 2). The limited data available did not permit 
us to assess the impact of children’s PCV status on AMR.
When restricting the AMR definition to resistance strains 
only, antibiotic resistance rates of S. pneumoniae to the various 
antibiotics were considerably lower (Table, Supplemental Digital 
Content 6, http://links.lww.com/INF/E359).
DISCUSSION
This systematic review of studies conducted in the post-
PCV era showed that, in children with AOMd, any bacterium is 
isolated in >3 quarter of middle ear fluid samples and that S. pneu-
monia, H. influenzae, S. aureus and S. pyogenes are the most preva-
lent bacteria.
A 2016 literature review found that S. pneumoniae (aver-
age detection rate: 27.8%) and H. influenzae (23.1%) are also the 
predominant bacteria in children with AOMwd globally7; S. aureus 
and S. pyogenes are, however, more common in AOMd than in 
AOMwd.7,35,36 Also, a bacterium is more frequently isolated in chil-
dren with AOMd than in those with AOMwd [any bacterium identi-
fied in 76% (range 48.7%–100%) versus 62% (range 25%–95%),7 
FIGURE 1. Flow chart included studies.
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respectively]. These findings add to the growing body of evidence 
that AOMwd and AOMd might be regarded as different parts of the 
spectrum of the AOM disease entity.
Theoretically, prevalences of bacteria isolated in AOMd 
and AOMwd may differ due to the sampling technique; the mid-
dle ear fluid from children with AOMd is obtained from visible 
FIGURE 2. Prevalence rates of Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus and no bacterium 
according to year.
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ear discharge in the external ear canal and may be contaminated 
with commensal bacteria. In AOMwd, tympanocentesis is required 
to obtain a middle ear fluid sample from children, with this proce-
dure contamination with commensal bacteria is less likely. With 
S. aureus being a common component of the microbiota in the ear 
canal, one may argue that this leads to an overestimation of this 
bacterium in AOMd. There is, however, increasing evidence that S. 
aureus should be regarded as an important upper respiratory tract 
pathogen originating from the nasopharyngeal niche.37,38 This is 
further substantiated by a recent study in children with ventilation 
tubes who developed acute ear discharge; it found a high correla-
tion between the abundances of S. aureus in nasopharynx and otor-
rhea samples.39,40
In our study, nonsusceptibility rates of S. pneumoniae to 
penicillin in AOMd varied between 0% and 65.8% (median 10.0%). 
A pooled analysis including 10 studies of children with AOMwd 
showed an average nonsusceptibility rate of 18.5%.36 We found no 
clear evidence of a shift in AMR over time in AOMd which is in 
agreement with a recent review of studies involving children with 
AOMwd,35 but the small sample means inferences must be cau-
tious. Besides that, AMR data should be interpreted in the context 
of PCV status, availability and adherence to local AOM guidelines 
and general antibiotic since this may substantially impact AMR.
To our knowledge, we are the first to systematically synthe-
size prevalences of bacteria and their AMR profile in children with 
AOMd. To capture only data relevant to our study population of inter-
est, that is, children with AOMd, and to avoid contamination with 
chronic suppurative otitis media cases, we excluded all studies that 
did not provide data for children with AOMd only or in which the 
diagnosis was not explicitly described. We prospectively registered 
our study protocol.15 While conducting this review, we broadened the 
scope of our review by also including data on the prevalence of bac-
teria in children with AOMd. Because we designed very broad litera-
ture search syntaxes—including the names of the individual bacteria 
of interest—and reviewed all reference lists of relevant studies, we 
consider it unlikely that we missed any relevant data.
Some important limitations deserve further attention. First, 
while large numbers of studies have been published on the preva-
lence of bacteria in children with AOMwd,7,41 relatively few studies 
have focused on children with AOMd. Large differences between 
studies (eg, number of participants, design, country and setting of 
conduct) resulted in substantial clinical and statistical heterogeneity 
across studies which did not allow us to calculate summary statis-
tics. Second, most studies relied on conventional culture to identify 
bacteria. This has likely resulted in an underestimation of the preva-
lence rate of bacteria because PCR techniques are more accurate 
than culture in detection of bacteria in middle ear fluid.7,36,42 Third, 
the absence of evidence of a shift in microbiology profiles over time 
in our review should be interpreted in the context of the limited 
available information on children’s PCV status and the few data of 
recent years. Previous studies of childhood AOMwd showed that the 
introduction of more-valent PCVs has led to a shift in otopathogens 
from vaccine-type pneumococci to nonvaccine-type pneumococci 
and other otopathogens including nontypeable H. Influenza and S. 
aureus and impacted AMR patterns.12–14,43 However, the data from 
included studies in this review are too limited to draw any meaning-
ful conclusion regarding the shift of bacteria from the early post-
PCV to the late post-PCV years. Fourth, this review did not focus 
on viruses. Virus alone can cause AOM (around 5% of middle ear 
fluid samples of children with AOMwd contain only viruses)44 and 
evidence is accumulating that the interplay between viruses and 
bacteria in the upper respiratory tract may play an important role.45 
In our sample of studies, no one did report data on viruses. Future 
studies should focus on the interplay between viruses and bacteria 
during upper respiratory tract infections and the progression to 
AOM to initiate new (preventive) interventions.
Finally, we excluded children with complicated AOM, 
including those with treatment failure, from our analysis to maxi-
mize generalizability of our review findings to children with AOMd 
presenting to primary care and limit the potential impact of previ-
ous antibiotic exposure to the microbiology profile as much as pos-
sible. As a consequence, we were unable to link the microbiology 
data to the risk of severe intracranial or extracranial suppurative 
complications and/or hospitalizations. Future research is needed to 
bridge this knowledge gap.
CONCLUSION
In children with AOMd S. pneumoniae and H. influenzae are 
the 2 predominant bacteria, followed by S. aureus and S. pyogenes, 
in the post-PCV era. Antimicrobial resistance data were sparse and 
mainly limited to S. pneumoniae. No clear change over time was 
observed. The limited data available did not permit us to assess the 
impact of children’s PCV status, and therefore ongoing surveillance 
of the microbiology profile is warranted.
REFERENCES
 1. Gulliford M, Latinovic R, Charlton J, et al. Selective decrease in consulta-
tions and antibiotic prescribing for acute respiratory tract infections in UK 
primary care up to 2006. J Public Health (Oxf). 2009;31:512–520.
 2. van den Broek d’Obrenan J, Verheij TJ, Numans ME, et al. Antibiotic use in 
Dutch primary care: relation between diagnosis, consultation and treatment. 
J Antimicrob Chemother. 2014;69:1701–1707.
 3. Rovers MM, Glasziou P, Appelman CL, et al. Antibiotics for acute otitis 
media: a meta-analysis with individual patient data. Lancet. 2006;368:1429–
1435.
 4. Smith L, Ewings P, Smith C, et al. Ear discharge in children presenting with 
acute otitis media: observational study from UK general practice. Br J Gen 
Pract. 2010;60:101–105.
 5. Damoiseaux RAMJ, Venekamp RP, Eekhof JAH, et al. NHG-Standaard Otitis 
media acuta bij kinderen (derde herziening). Huisarts Wet. 2014;57:648.
 6. Centre for Clinical Practice at NICE (UK). National Institute for Health 
and Clinical Excellence: Guidance. Respiratory Tract Infections - Antibiotic 
Prescribing: Prescribing of Antibiotics for Self-Limiting Respiratory Tract 
Infections in Adults and Children in Primary Care. National Institute for 
Health and Clinical Excellence (UK); 2008.
 7. Ngo CC, Massa HM, Thornton RB, et al. Predominant bacteria detected 
from the middle ear fluid of children experiencing otitis media: a systematic 
review. PLoS One. 2016;11:e0150949.
 8. Segal N, Givon-Lavi N, Leibovitz E, et al. Acute otitis media caused by 
Streptococcus pyogenes in children. Clin Infect Dis. 2005;41:35–41.
 9. Leibovitz E, Serebro M, Givon-Lavi N, et al. Epidemiologic and microbio-
logic characteristics of culture-positive spontaneous otorrhea in children 
with acute otitis media. Pediatr Infect Dis J. 2009;28:381–384.
 10. Stamboulidis K, Chatzaki D, Poulakou G, et al. The impact of the heptava-
lent pneumococcal conjugate vaccine on the epidemiology of acute otitis 
media complicated by otorrhea. Pediatr Infect Dis J. 2011;30:551–555.
 11. Brook I, Gober AE. Bacteriology of spontaneously draining acute otitis 
media in children before and after the introduction of pneumococcal vac-
cination. Pediatr Infect Dis J. 2009;28:640–642.
 12. Casey JR, Kaur R, Friedel VC, et al. Acute otitis media otopathogens during 
2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32:805–809.
 13. Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiol-
ogy, and antibiotic treatment of acute otitis media in children: a systematic 
review. JAMA. 2010;304:2161–2169.
 14. Kaur R, Morris M, Pichichero ME. Epidemiology of acute otitis media in the 
postpneumococcal conjugate vaccine era. Pediatrics. 2017;140:e20170181.
 15. Hullegie S, Venekamp RP, van Dongen TMA, et al. Global prevalence of 
antibiotic resistance of bacteria in the nasopharynx and middle ear from 
children with acute otitis media and the resistance impact of oral and topi-
cal antibiotics: a systematic review. PROSPERO 2018 CRD42018100523. 
Available at: https://www.crd.york.ac.uk/prospero/display_record.
php?ID=CRD42018100523. 
 The Pediatric Infectious Disease Journal • Volume 40, Number 8, August 2021
762 | www.pidj.com © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Hullegie et al
 16. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for report-
ing systematic reviews and meta-analyses of studies that evaluate health care 
interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
 17. Institute JB. Critical Appraisal Tools. Checklist for Prevalence Studies. 
2017. Available at: https://jbi.global/sites/default/files/2020-08/Checklist_
for_Prevalence_Studies.pdf. Accessed April 2, 2019.
 18. Rothman KJ. Episheet Spreadsheets for the Analysis of Epidemiologic Data. 
2011. Available at: http://krothman.hostbyet2.com/Episheet.xls.
 19. Ubukata K, Morozumi M, Sakuma M, et al; AOM Surveillance Study 
Group. Etiology of acute otitis media and characterization of pneumococcal 
isolates after introduction of 13-valent pneumococcal conjugate vaccine in 
Japanese children. Pediatr Infect Dis J. 2018;37:598–604.
 20. Naziat H, Saha S, Islam M, et al. Epidemiology of otitis media with otorrhea 
among Bangladeshi children: baseline study for future assessment of pneu-
mococcal conjugate vaccine impact. Pediatr Infect Dis J. 2018;37:715–721.
 21. Ding YL, Fu J, Chen J, et al. Molecular characterization and antimicrobial 
susceptibility of Staphylococcus aureus isolated from children with acute 
otitis media in Liuzhou, China. BMC Pediatr. 2018;18:388.
 22. Rosenblut A, Napolitano C, Pereira A, et al. Etiology of acute otitis media and 
serotype distribution of Streptococcus pneumoniae and Haemophilus influen-
zae in Chilean children <5 years of age. Medicine (Baltimore). 2017;96:e5974.
 23. Sonsuwan N, Watcharinyanon P, Sawanyawisuth K. What are the leading 
causative pathogens in acute otitis media with tympanic membrane perfora-
tion? Int J Pediatr Otorhinolaryngol. 2016;90:20–22.
 24. Ding Y, Geng Q, Tao Y, et al. Etiology and epidemiology of children with 
acute otitis media and spontaneous otorrhea in Suzhou, China. Pediatr 
Infect Dis J. 2015;34:e102–e106.
 25. van der Linden M, Imöhl M, Busse A, et al. Bacterial spectrum of spontane-
ously ruptured otitis media in the era of pneumococcal conjugate vaccina-
tion in Germany. Eur J Pediatr. 2015;174:355–364.
 26. Lee JS, Kim MG, Hong SM, et al. Changing patterns of bacterial strains in 
adults and children with otitis media in Korean tertiary care centers. Clin 
Exp Otorhinolaryngol. 2014;7:79–86.
 27. Setchanova LP, Kostyanev T, Alexandrova AB, et al. Microbiological char-
acterization of Streptococcus pneumoniae and non-typeable Haemophilus 
influenzae isolates as primary causes of acute otitis media in Bulgarian 
children before the introduction of conjugate vaccines. Ann Clin Microbiol 
Antimicrob. 2013;12:6.
 28. Rodrigues F, Morales-Aza B, Turner KM, et al. Multiple Streptococcus pneu-
moniae serotypes in aural discharge samples from children with acute otitis 
media with spontaneous otorrhea. J Clin Microbiol. 2013;51:3409–3411.
 29. Marchisio P, Bianchini S, Baggi E, et al. A retrospective evaluation of 
microbiology of acute otitis media complicated by spontaneous otorrhea in 
children living in Milan, Italy. Infection. 2013;41:629–635.
 30. Grevers G, Wiedemann S, Bohn JC, et al. Identification and characterization 
of the bacterial etiology of clinically problematic acute otitis media after 
tympanocentesis or spontaneous otorrhea in German children. BMC Infect 
Dis. 2012;12:312.
 31. Sierra A, Lopez P, Zapata MA, et al. Non-typeable Haemophilus influenzae 
and Streptococcus pneumoniae as primary causes of acute otitis media in 
colombian children: a prospective study. BMC Infect Dis. 2011;11:4.
 32. Neumark T, Ekblom M, Brudin L, et al. Spontaneously draining acute otitis 
media in children: an observational study of clinical findings, microbiology 
and clinical course. Scand J Infect Dis. 2011;43:891–898.
 33. Junejo AA, Abbasi KA, Chand H, et al. Bacterial pathogens and their drug 
sensitivity pattern in acute otitis media in children at children hospital 
chandka medical college Larkana. Medical Channel. 2011;17:50–55.
 34. Cilveti R, Olmo M, Pérez-Jove J, et al; HERMES Study Group. 
Epidemiology of otitis media with spontaneous perforation of the tympanic 
membrane in young children and association with bacterial nasopharyngeal 
carriage, recurrences and pneumococcal vaccination in Catalonia, Spain - 
the Prospective HERMES Study. PLoS One. 2017;12:e0170316.
 35. Mather MW, Drinnan M, Perry JD, et al. A systematic review and meta-
analysis of antimicrobial resistance in paediatric acute otitis media. Int J 
Pediatr Otorhinolaryngol. 2019;123:102–109.
 36. Van Dyke MK, Pirçon JY, Cohen R, et al. Etiology of acute otitis media in 
children less than 5 years of age: a pooled analysis of 10 similarly designed 
observational studies. Pediatr Infect Dis J. 2017;36:274–281.
 37. Chan CL, Wabnitz D, Bassiouni A, et al. Identification of the bacterial reser-
voirs for the middle ear using phylogenic analysis. JAMA Otolaryngol Head 
Neck Surg. 2017;143:155–161.
 38. Brook I, Yocum P, Shah K. Aerobic and anaerobic bacteriology of otor-
rhea associated with tympanostomy tubes in children. Acta Otolaryngol. 
1998;118:206–210.
 39. van Dongen TM, Venekamp RP, Wensing AM, et al. Acute otorrhea in 
children with tympanostomy tubes: prevalence of bacteria and viruses 
in the post-pneumococcal conjugate vaccine era. Pediatr Infect Dis J. 
2015;34:355–360.
 40. Man WH, van Dongen TMA, Venekamp RP, et al. Respiratory microbiota 
predicts clinical disease course of acute otorrhea in children with tympanos-
tomy tubes. Pediatr Infect Dis J. 2019;38:e116–e125.
 41. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media 
pathogens. Pediatr Infect Dis J. 1992;11(8 suppl):S7–S11.
 42. Smith-Vaughan HC, Binks MJ, Marsh RL, et al. Dominance of Haemophilus 
influenzae in ear discharge from indigenous Australian children with acute 
otitis media with tympanic membrane perforation. BMC Ear Nose Throat 
Disord. 2013;13:12.
 43. de Sévaux JLH, Venekamp RP, Lutje V, et al. Pneumococcal conjugate vac-
cines for preventing acute otitis media in children. Cochrane Database Syst 
Rev. 2020;11:CD001480.
 44. Chonmaitree T, Ruohola A, Hendley JO. Presence of viral nucleic acids in 
the middle ear: acute otitis media pathogen or bystander? Pediatr Infect Dis 
J. 2012;31:325–330.
 45. van den Bergh MR, Biesbroek G, Rossen JW, et al. Associations between 
pathogens in the upper respiratory tract of young children: interplay between 
viruses and bacteria. PLoS One. 2012;7:e47711.
